BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29108005)

  • 21. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy.
    Bertucci F; Finetti P; Rougemont J; Charafe-Jauffret E; Nasser V; Loriod B; Camerlo J; Tagett R; Tarpin C; Houvenaeghel G; Nguyen C; Maraninchi D; Jacquemier J; Houlgatte R; Birnbaum D; Viens P
    Cancer Res; 2004 Dec; 64(23):8558-65. PubMed ID: 15574762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Provance OK; Lewis-Wambi J
    Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory breast cancer: The pathologists' perspective.
    Cserni G; Charafe-Jauffret E; van Diest PJ
    Eur J Surg Oncol; 2018 Aug; 44(8):1128-1134. PubMed ID: 29706301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
    Bertucci F; Finetti P; Rougemont J; Charafe-Jauffret E; Cervera N; Tarpin C; Nguyen C; Xerri L; Houlgatte R; Jacquemier J; Viens P; Birnbaum D
    Cancer Res; 2005 Mar; 65(6):2170-8. PubMed ID: 15781628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
    Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
    Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Gene Expression of fresh tissue and patient-derived explants' matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1.
    Tarek A; Mohamed HT; El-Sharkawy AA; El-Sayed SK; Hirshon JM; Woodward WA; El-Shinawi M; Mohamed MM
    QJM; 2023 May; 116(5):345-354. PubMed ID: 36592055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
    Gong Y; Huo L; Liu P; Sneige N; Sun X; Ueno NT; Lucci A; Buchholz TA; Valero V; Cristofanilli M
    Cancer; 2011 Dec; 117(24):5476-84. PubMed ID: 21713757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and outcome characteristics of inflammatory breast cancers in Brazzaville].
    N'koua-M'bon JB; Bambara AT; Moukassa D; Gombé-Mbalawa C
    Bull Cancer; 2013 Feb; 100(2):147-53. PubMed ID: 23392567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust inflammatory breast cancer gene signature using nonparametric random forest analysis.
    Zare A; Postovit LM; Githaka JM
    Breast Cancer Res; 2021 Sep; 23(1):92. PubMed ID: 34579745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.
    Alexander A; Karakas C; Chen X; Carey JP; Yi M; Bondy M; Thompson P; Cheung KL; Ellis IO; Gong Y; Krishnamurthy S; Alvarez RH; Ueno NT; Hunt KK; Keyomarsi K
    Oncotarget; 2017 Feb; 8(9):14897-14911. PubMed ID: 28107181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory breast cancer biology: the tumour microenvironment is key.
    Lim B; Woodward WA; Wang X; Reuben JM; Ueno NT
    Nat Rev Cancer; 2018 Aug; 18(8):485-499. PubMed ID: 29703913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration.
    Buchheit CL; Angarola BL; Steiner A; Weigel KJ; Schafer ZT
    Cell Death Differ; 2015 Aug; 22(8):1275-86. PubMed ID: 25526094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Treatment Strategies for the Inflammatory Breast Cancer.
    Vagia E; Cristofanilli M
    Curr Treat Options Oncol; 2021 Apr; 22(6):50. PubMed ID: 33893888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
    El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
    Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
    Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
    Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
    Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
    Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchrotron Fourier-Transform Infrared Microspectroscopy: Characterization of in vitro polarized tumor-associated macrophages stimulated by the secretome of inflammatory and non-inflammatory breast cancer cells.
    Mohamed HT; Kamel G; El-Husseiny N; El-Sharkawy AA; El-Sherif AA; El-Shinawi M; Mohamed MM
    Biochim Biophys Acta Mol Cell Res; 2023 Jan; 1870(1):119367. PubMed ID: 36202317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
    Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
    J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy.
    Bertucci F; Finetti P; Colpaert C; Mamessier E; Parizel M; Dirix L; Viens P; Birnbaum D; van Laere S
    Oncotarget; 2015 May; 6(15):13506-19. PubMed ID: 25940795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.